# Multi-tissue transcriptomic study reveals the main role of liver in the chicken adaptive response to a switch in dietary energy source through the transcriptional regulation of lipogenesis

Colette Désert, Elisabeth Baéza, Meziane Aite, Morgane Boutin, Aurélie Le Cam, Jérôme Montfort, M. Houee-Bigot, Yuna Blum, Pierre-François Roux, Christelle Hennequet-Antier, et al.

► To cite this version:

Colette Désert, Elisabeth Baéza, Meziane Aite, Morgane Boutin, Aurélie Le Cam, et al. Multi-tissue transcriptomic study reveals the main role of liver in the chicken adaptive response to a switch in dietary energy source through the transcriptional regulation of lipogenesis. BMC Genomics, 2018, 19 (1), pp.1-19. 10.1186/s12864-018-4520-5. hal-01727161

HAL Id: hal-01727161

https://hal.science/hal-01727161

Submitted on 8 Mar 2018

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
RESEARCH ARTICLE

Open Access

<figure><img src="image_2.png" /></figure>

CrossMark

# Multi-tissue transcriptomic study reveals the main role of liver in the chicken adaptive response to a switch in dietary energy source through the transcriptional regulation of lipogenesis

C. Desert<fnref n="1" />*†, E. Baéza²†, M. Aite<fnref n="1" />, M. Boutin<fnref n="1" />, A. Le Cam³, J. Montfort³, M. Houee-Bigot⁴, Y. Blum<fnref n="1" />,⁵, P. F. Roux<fnref n="1" />,⁶, C. Hennequet-Antier², C. Berri², S. Metayer-Coustard², A. Collin², S. Allais<fnref n="1" />, E. Le Bihan², D. Causeur⁴, F. Gondret<fnref n="1" />, M. J. Duclos² and S. Lagarrigue<fnref n="1" />*

**Abstract**

**Background:** Because the cost of cereals is unstable and represents a large part of production charges for meat-type chicken, there is an urge to formulate alternative diets from more cost-effective feedstuff. We have recently shown that meat-type chicken source is prone to adapt to dietary starch substitution with fat and fiber. The aim of this study was to better understand the molecular mechanisms of this adaptation to changes in dietary energy sources through the fine characterization of transcriptomic changes occurring in three major metabolic tissues – liver, adipose tissue and muscle – as well as in circulating blood cells.

**Results:** We revealed the fine-tuned regulation of many hepatic genes encoding key enzymes driving glycogenesis and de novo fatty acid synthesis pathways and of some genes participating in oxidation. Among the genes expressed upon consumption of a high-fat, high-fiber diet, we highlighted CPT1A, which encodes a key enzyme in the regulation of fatty acid oxidation. Conversely, the repression of lipogenic genes by the high-fat diet was clearly associated with the down-regulation of SREBF1 transcripts but was not associated with the transcript regulation of MLXIPL and NR1H3, which are both transcription factors. This result suggests a pivotal role for SREBF1 in lipogenesis regulation in response to a decrease in dietary starch and an increase in dietary PUFA. Other prospective regulators of de novo hepatic lipogenesis were suggested, such as PPARD, JUN, TADA2A and KAT2B, the last two genes belonging to the lysine acetyl transferase (KAT) complex family regulating histone and non-histone protein acetylation. Hepatic glycogenic genes were also down-regulated in chickens fed a high-fat, high-fiber diet compared to those in chickens fed a starch-based diet. No significant dietary-associated variations in gene expression profiles was observed in the other studied tissues, suggesting that the liver mainly contributed to the adaptation of birds to changes in energy source and nutrients in their diets, at least at the transcriptional level. Moreover, we showed that PUFA deposition observed in the different tissues may not rely on transcriptional changes.

**Conclusion:** We showed the major role of the liver, at the gene expression level, in the adaptive response of chicken to dietary starch substitution with fat and fiber.

**Keywords:** Chicken, Lipid, Adaptation, Fat diet, Gene expression, Regulation, PUFA, SREBF1, TADA2A

<footnote>* Correspondence: colette.desert@agrocampus-ouest.fr; sandrine.lagarrigue@agrocampus-ouest.fr</footnote>

<footnote n="1">¹Equal contributors</footnote>

<footnote n="1">¹Pegase, INRA, Agrocampus Ouest, 35042 Rennes, France
Full list of author information is available at the end of the article</footnote>
## Background

Feed costs represent more than 60% of charges in meat production from non-ruminant species such as chicken. It is therefore of interest to identify nutritional strategies that could reduce production costs while maintaining production performances. Because cereal costs have increased dramatically over the past 2 years, alternative diets with fiber-rich co-products show a valuable perspective from an economic point of view. To sustain production traits such as growth or breast muscle weight, dietary energy primarily derived from starch in cereal-based diets must be maintained by adding fat sources such as vegetable oils to fiber-rich diets. This results in changing both energy sources and nutrients in diets. To date, different studies have investigated the effects of dietary energy sources, particularly the impact of carbohydrate substitution by fat on growth performance and body composition in meat-type chicken. Plavnik et al. [1] analyzed the effects of using fat vs. carbohydrates (starch grains) in the diets of 7- to 49-day-old broiler chickens. Adrizal et al. [2] compared the effects of a diet based on defatted rice bran supplemented with fat vs. a conventional corn soybean diet in broilers from 4 to 35 days of age. Recently, we evaluated the effects of two diets with either high-lipid, high-fiber content (HF diet) or high-starch content (LF diet) in 22-to 63-day-old broiler chickens [3]. In this study, cellulose – a compound resistant to digestion in the small intestine – was used as an insoluble fiber source in the HF diet, as it was considered a simple diluent of energy. In these three studies, no effect of diets was observed on production performance (i.e., weight gain, feed efficiency or body composition), showing that chicken is prone to adapt to variations in dietary energy sources. This differs from the results obtained in other non-ruminant species, such as pigs, where marked decreases in feed ingestion, weight gain and body fat content have been observed with high-fat, high-fiber diets [4]. However, the molecular mechanisms associated with chicken adaptation to changes in energy source and nutrients have never been investigated. In this context, the present study aimed to evaluate the molecular responses of tissues involved in energy homeostasis to dietary energy sources in chickens by using a transcriptomic approach and proposing key regulators of metabolic pathways. Assuming the involvement of lipid metabolism – one of the keystones underlying energy homeostasis – in this adaptation process, we also compared responses between two broiler lines divergent for abdominal fat content for evaluating an eventual interaction between diet and genotype on gene expression. The three tissues investigated were i) the liver, the key lipogenic organ in birds, which is also involved in many other physiological processes such as oxidation, secretion and detoxification; ii) the white

adipose tissue, which is critical for fatty acid storage; and iii) the *Pectoralis* major muscle, one of the most energy-consuming tissues considering its mass. The peripheral blood mononuclear cells (PBMCs) were also analyzed since many studies have now highlighted their relevance to understanding body energy homeostasis, metabolic disease and immunity [5–7]. Because chicken fills a large evolutionary gap between sauropsids and mammals, the present study also aimed to provide new insights into the conservation of the regulatory networks involved in lipid homeostasis. We showed that the main metabolism impacted by changes in dietary energy sources was fatty acid (FA) metabolism, particularly FA synthesis and polyunsaturated FA (PUFA) deposition in the liver. The present study therefore provided a physiological model to provide a better understanding of the regulation of lipogenic gene expression by dietary FA in chickens and the involved transcription factors. We highlighted known and potential regulator genes for this metabolism by combining differential expression, co-expression and genomics co-localization analyses.

## Methods

### Animals and diets

A total of 64 broiler males from two experimental lines (32 per line) divergently selected for abdominal fat content (fat and lean lines, [8]) was obtained from the "Pôle Expérimental Avicole de Tours" (INRA, Nouzilly, France). A total of 2 × 16 chickens per line were grown in individual cages and fed the two experimental diets from 21 to 63 days (d) of age. To limit genetic variation, two full sibs from a given family were assigned in one of the two dietary groups. These two diets were isocaloric (12.54 MJ ME/kg) and isonitrogenous (190 g CP/kg) but exhibited either a high-starch and low-fiber low-lipid contents (LF diet) or a low-starch, high-fiber and high-lipid contents (HF diet). Starch derived from wheat seeds in the LF diet considered as the standard diet was partially replaced by rapeseed and soybean oils in the HF diet, and cellulose (insoluble fiber) was included to dilute dietary energy in this specific diet. Consequently, diets showed large variations in starch (51% vs. 38%, for LF and HF diets, respectively), fat (2% vs. 8%), and cellulose (2.1% vs. 6.4%) contents. The amounts of saturated, mono-unsaturated and poly-unsaturated fatty acids were similar in the two diets. Detailed compositions of LF and HF diets are precisely described in our previous study [3] and are summarized in the Additional file 1.

### Tissue sampling

At 63 days of age, 12 chickens per line and per diet were selected for slaughtering: only animals with a body weight close to the average weight of their group were considered to limit inter-individual variability. Chickens
were killed 3 h after the last meal intake by decapitation and bleeding. Chickens were previously anaesthetized by bi-temporal electronarcosis. Right after slaughter, liver, *Pectoralis major* muscle and abdominal fat were sampled, snap frozen in liquid nitrogen and stored at – 80 °C until analyses. To prepare peripheral blood mononuclear cells (PBMC), whole blood was collected in the occipital sinus in EDTA tubes. Two mL were centrifuged for 10 min at 2000 g, 4 °C and plasma aliquots were stored at – 20 °C before defining plasmatic parameters. Two additional mL were diluted with an equal volume of 1X PBS, mixed by pipetting and deposited on 3 mL Ficoll (Histopaque 1077, Sigma-Aldrich, Saint-Quentin Fallavier, France). We then proceeded to continuous density gradient centrifugation at 720 g for 10 min without brake. The interphase was collected and washed twice with PBS and PBMC pellet was finally snap frozen in liquid nitrogen and kept at – 80 °C.

## Metabolites and traits

Seven traits related to growth performance and body composition were recorded for the 48 birds: body weight (g), average daily gain (g), average daily feed intake (g/day/bird), *Pectoralis major* muscle weight (g), abdominal fat weight (g), and liver weight (g). We further measured lipid content in liver, adipose tissue and *Pectoralis major* muscle – data are expressed in % (g / 100 g tissue) according to [9]. VLDL, LDL and HDL lipoproteins were determined in plasma according to [10]. Glucose, glycogen and lactate levels were measured in liver following the procedure described in Dalrymple and Hamm [11]. Total cholesterol (mg/L), phospholipids (mg/mL), triglycerides (mg/L) and FA composition (C14:0, C16:0, C16:1, C18:0, C18:1, C18:2, C18:3, C20:0, C20:1, C20:4, C20:5, C22:5, C22:6, % of total lipids) were assessed in liver according to methods described in Chartrin et al. [9]. We finally used these elementary variables to compute the relative percentages in SFA (saturated FA), MFA (mono-unsaturated FA) and PUFA (poly-unsaturated FA), n-6 and n-3 FA families, as well as the n-6/n-3 ratio. For additional information about methods and measures, see [3, 10]. A Student t test was performed using the t.test function in R for testing the dietary effect in each of the three FA classes.

## RNA isolation

Liver (30 mg), muscle (30 mg), adipose tissue (100 mg) samples and PBMC pellet were homogenized in TRIzol (Invitrogen, California, USA). Total RNA was then extracted according to manufacturer's instructions, re-suspended in 50 µL of RNase-free water and stored at – 80 °C. Total RNA was quantified on a NanoDrop® ND-1000 spectrophotometer (Thermo Scientific, Illkirch,

France). Absorbance ratios A260/280 and A260/230 were over 1.7 for all samples. RNA preparations were finally quality checked on an Agilent 2100 Bioanalyzer (Agilent Technologies France, Massy, France). Average RNA integrity numbers were 9.4 ± 0.5 for liver, 8.4 ± 0.5 for muscle, 8.0 ± 0.6 for abdominal tissue, 8.8 ± 0.5 for PBMC.

## Gene expression microarray: Data acquisition

The Agilent custom 8 × 60 K chicken gene expression microarray (GPL19630 for GEO database, and ID042004 for Agilent database) used in this study contained the 43,553 probes from the Agilent commercial 44 K collection (ID 026441, Agilent Technologies France, Massy, France) supplemented with 756 probes genes annotated with GO terms related to lipid metabolism, 5821 additional probes known to be expressed in chicken muscle, adipose tissue and liver according to previous experiments [12] and 955 additional probes corresponding to genes not represented in the standard Agilent collection. All these probes corresponded to 16,736 genes referenced in the chicken Ensembl V70 annotation (http://www.ensembl.org/index.html): 50% of the genes were represented by at least 4 probes, whereas 4464 genes were represented by only 1 probe. The human orthologs have been systematically identified according to the “one-to-one” criteria defined by the Ensembl consortium: 69% out of the 16,736 chicken genes have a one-to-one ortholog, allowing us to retrieve for these genes a human HGNC gene symbol from which we could extract more Gene Ontology (GO) annotations.

Total RNA (150 ng per sample) was labelled with Cy3 dye using the Low Input Quick Amp Labeling kit (Agilent Technologies) following the manufacturer's instructions. Cy3-labeled cRNA samples were purified, fragmented, and hybridized onto Agilent custom microarray at 65 °C for 17 h using Agilent's Gene Expression Hybridization Kit. After washing 2 × 1 min at room temperature and then at 37 °C, microarrays were scanned using the Agilent DNA Microarray Scanner G2505C, and images were processed with Agilent Feature Extraction Software (Version 10.7.3.1). Finally, 48, 46, 48 and 44 arrays for liver, adipose, muscle and PBMC respectively were available after hybridization and scan.

## Gene expression microarray: data analysis

All analyses were performed using the R software version 3.1.0. Expression dataset were filtered according to different criteria provided by Agilent: two criteria related to spot quality (gIsManualFlag = 0 & gIsFeatNonUnifOL = 0) and one criterion related to spot fluorescence (gIsWellAboveBG = 1). For the 44 to 48 microarrays available per tissue, the mean percentage of spots discarded according to these standards was lower than 0.5% per microarray,
suggesting that technical procedures, from slide production to labelling and hybridization, were successful. A gene was then considered as expressed in one given tissue if at least 80% of its related spots in at least one condition satisfied the three criteria defined above.

Intensities of remaining spots were finally log2 transformed. An in-depth quality-check was conducted on raw data to identify potential outlier by using principal component analysis (PCA) (Additional file 2) and analysis of background and signal intensity variation. This step allowed us to point out some outlier arrays which have been further discarded: 2, 1, 3 and 2 outlier arrays were identified out for liver, adipose, muscle and PBMC respectively. We finally analyzed 178 microarrays: 46, 45, 45 and 42 for liver, adipose, muscle and PBMC respectively. Data were normalized by median centering by array and analyzed by using a two-way analysis of variance (with the R function: Anova (lm())) with line, diet and interaction between line and diet as main effects. An analysis using Limma package [13] provided similar results as Anova. The row p-values for each factor (line, diet, line x diet) were adjusted following the Benjamini and Hochberg (BH) multiple testing correction method [14] to control the False Discovery Rate. An adjusted p-value < 0.05 threshold and an absolute fold-change >= 1.2 cut-off between conditions were considered as a heuristic way to retain robust differentially expressed probes (DEP) and associated differentially expressed genes (DEG).

### BioMark™ real-time PCR analysis

Total RNA isolated from the 48 chickens was reverse-transcribed using High-Capacity cDNA Reverse Transcription kit (Applied Biosystems, Foster City, CA) following manufacturer's instructions. cDNAs was diluted 1:20 and subjected to a Specific Target Amplification step using Pre-Amp Master Mix kit (Fluidigm Corporation) with a mixture of all primer pairs and 14 cycles of pre-amplification. The BioMark™ 96.96 Dynamic Array (Fluidigm Corporation) for real-time qPCR was used to simultaneously measure the expression of selected genes using Real-Time PCR Analysis User Guide PN 68000088 K1. Primers used for qPCR reactions are listed in Additional file 3. Data were analyzed using HTqPCR R package [15] and normalized considering GAPDH, RPS8 and TOP2B as reference genes, as suggested after GeNoRm analysis [16].

### Fatty acid synthase (FASN) enzyme activity

The activity of fatty acid synthase (FASN), a key lipogenic enzyme, was assayed in liver. Tissue samples were first homogenized in 0.25 M ice-cold sucrose solution containing EDTA (1 mM) and dithiothreitol (DTT, 1 mM). Mixtures were ultra-centrifuged at 100,000 x g during 1 h at +4 °C. The resulting supernatants

containing cytosolic proteins were collected and frozen at -80 °C until use. Activity was then assayed on a spectrophotometer at 340 nm absorbance [17] and expressed per unit of cytosolic proteins.

### Functional pathway analysis using GO database

A hypergeometric test was used to select over-represented GO terms for the DEG lists. As a background, we considered all the genes expressed in the analyzed tissue. Our home-made script provided the GO Identifiers, the GO terms, the p-value adjusted following Benjamini-Hochberg procedure, the HGNC of genes related to the enriched GO term and their fold-change in expression between diets. The GO terms were considered as over-represented if the corrected p-value was < 0.1. Redundant GO terms were finally removed using Revigo [18] and they were manually grouped into representative ancestor terms. An analysis using the webtool DAVID (http://david.abcc.ncifcrf.gov/ [19]) was also carried out and provided similar results.

### Analysis of potential regulatory genes responsible for transcriptome variations

Based on the 2 DEG lists (e.g. down or up regulated by HF diet vs. standard LF diet), potential upstream regulators were defined using different approaches. First, we identified genes encoding a transcription factor or a hormone by looking for GO terms annotations specific to these two types of proteins. Second, we used these DEG lists as inputs for IPA (IPA* - Ingenuity Systems Inc., Redwood City, CA - https://www.ingenuity.com/) to identify potential upstream regulators suggested by this software [20].

### Multiple factor analysis (MFA)

MFA data integration [21] was used to provide a simultaneous view of transcriptomic and metabolomic changes occurring after a diet shift in order to highlight communalities across the two heterogeneous datasets. MFA provides an individual relationship structure by simultaneously evaluating the variation in metabolites and differentially expressed genes (DEGs). When multiple probes matched to one gene, we synthesized the expression data at the gene level by selecting the most varying probe per gene. The MFA method was applied using FactoMiner R package. Briefly, the MFA consists in the following three steps: 1) two principal component analyses (PCA) were performed with the two datasets (here the expression table of the DEG list and the table of metabolite measurements), 2) the components of each PCA were weighed by the first eigenvalue to avoid biasing the MFA towards gene expression (several hundred variables vs. 25 variables for metabolites), 3) the MFA
analysis was performed using these weighed variables as new entries, so that expression and metabolite influence was equally distributed into MFA. The first two MFA components (called Dim1 & Dim2) were linked to the components of the two separate PCA by calculating the correlations between MFA and PCA components; in the present study, the two first axis/components of the two PCA were called Dim1_Expr & Dim2_Expr for the expression table and Dim1_Metab & Dim2_Metab for the metabolite table. This allows building a MFA diagnostic plot to study the relationship between the observations, the variables and the tables, facilitating the description of communalities. Calculating the correlations between each trait with the first two MFA dimensions allows deciphering the genes and metabolites mainly responsible for communalities in response to diet shift. A threshold *r* > 0.75 (p-value < 0.001) was used to extract these relevant variables. To facilitate the interpretation of the MFA results, diet and line factors were used in the MFA as illustrative variables (they do not contribute to the MFA components construction).

## Results

### Starch substitution with dietary fat and fiber had little effect on growth performance and body composition traits

In the present study, we considered growing chickens originated from two lines divergently selected for abdominal fat weight so that abdominal fat weight represented 3% of total body weight in the fat line and only 1% in the lean line (Fig. 1). Chickens from the two lines were fed either a low-starch, high-fiber, high-fat (HF) diet or a high-starch, low-fiber, low-fat (LF) diet for

6 weeks and were then killed at the same age. The two diets were formulated as isocaloric and isonitrogenous but differed in the dietary energy source available and nutrients.

Performance and body composition at the end of the feeding trial have been fully described in our previous study [3] and are only briefly summarized here (Fig. 1). For both lines, diets had no effects on growth performance and body composition, with the noticeable exception of the liver, which was lighter in birds fed an HF diet vs. an LF diet. Variation in liver weight was significantly correlated (0.53) with the expression of FASN encoding one of the key lipogenic enzymes (Fig. 1c). No interaction between diet and lines was observed for these phenotypes using the present dataset.

### Adaptation to starch substitution was mainly driven by liver transcriptomic changes

To understand the molecular mechanisms leading to the adaptation of birds to changes in dietary energy sources, we analyzed the transcriptomic changes associated with diet in three tissues involved in energy production and use and in circulating blood cells using microarrays. A total of 13,844 genes were expressed in at least one of the four tissues, representing 84% out of the 16,473 genes referenced in the Ensembl v70 annotation, with between 69 and 73% of genes expressed per tissue. Of these expressed genes, 10,870 (65%) were simultaneously expressed in the 3 metabolic tissues (liver, muscle and adipose), and 9689 (58%) were expressed in all 3 tissues and in PBMCs (Fig. 2a). More specifically, 11,844, 12,068, 12,020 and 11,381 genes were expressed in the liver, adipose tissue, muscle and PBMCs, respectively.

a

<figure><img src="image_3.png" /></figure>

<figure><img src="image_4.png" /></figure>

<figure><img src="image_5.png" /></figure>

c

<figure><img src="image_6.png" /></figure>

<figure><img src="image_7.png" /></figure>

<figure><img src="image_8.png" /></figure>

b

<figure><img src="image_9.png" /></figure>

<figure><img src="image_10.png" /></figure>

**Fig. 1** Diet effect on growth performance, body composition and organ weight, Two divergent Fat (solid bars) and Lean (hatched bars) meat-type chicken lines selected for abdominal fat weight, were fed during 6 weeks between 21 and 63 days an iso-caloric diet either enriched in lipids and fiber (HF diet, orange bars) or in starch (LF diet, blue bars). The values are means ± standard deviation with *n* = 12. **a** Growth performance and body composition. **b** Organ weights. **c** Correlation between liver/body weight ratio and FASN mRNA level. ***: *p*-value ≤0.001
<figure><img src="image_11.png" /><figcaption>**Fig. 2** Overview of gene expression and differential expression between diets in liver, adipose tissue, muscle and PBMC. a. Number of genes expressed in the 4 tissues. b Number of genes differentially expressed between diets in the 4 tissues. c Pearson correlation between expression fold change in liver (log2(FC)) for 50 genes analyzed by microarray (x-axis) and RT-qPCR (y-axis) in the same experimental design; Significance of the DEG by microarray is indicated by the following color chart: brown dots = *p*-value ≤0.001, orange dots = *p*-value ≤0.01, yellow dots = *p*-value ≤0.05, black dots = node (p.value > 0.05)</figcaption></figure>

Among these genes, only a few were tissue specific: 3% on average, with 411, 253, 358 and 355 genes being specific to liver, adipose tissue, muscle and PBMCs, respectively. These results were consistent with previous reports, suggesting that up to 60–70% of protein-coding genes are expressed in any given tissue [5, 12, 22], while very few genes are tissue specific [23–25].

Genotype had major effects in all tissues, with 3341, 3096, 1554 and 6192 DEGs in the liver, adipose tissue, muscle and PBMCs, respectively. No significant interaction between line and diet was observed in any tissues, enabling separate analyses of these two factors. We subsequently focused on the diet effect whereas the genotype effect will be analyzed in another study. Strikingly, regardless of the line, the diet has a significant effect on the transcriptome in the liver only, with 464 DEGs (1020 DEPs) between the HF and LF groups (Fig. 2b and Additional file 4). Among these DEGs, 50 genes were further assayed by RT-qPCR, and 45 genes were validated as being differentially expressed between diets (*p* < 0.05) (Additional file 4). We observed that the five invalidated genes (*p* > 0.05, PPARG, ADIPOR2, NFE2L1, SLC22A4 and SLC40A1, black dots in Fig. 2c) had a low expression fold-change between diets, despite the method used. A high correlation (r = 0.97) was

observed between the two methods for gene expression quantification (Fig. 2c). Another striking observation was the differential expression of a single gene in PBMCs: *CPT1A*, encoding the carnitine palmitoyltransferase 1, an enzyme involved in the mitochondrial fatty acid β-oxidation (Fig. 3e). All five probes located in either 3'UTR or coding regions show consistent HF/LF expression ratios approximately equal to 2. RT-qPCR assay further confirmed the diet effect on *CPT1A* expression in PBMCs (HF/LF expression = 1.67, *p* = 0.0003).

**Functional characterization of liver transcriptomic changes upon dietary starch substitution**

Among the 464 DEGs detected in the liver in response to a change in diet, 298 genes were under-expressed, and 166 genes were over-expressed in HF diet vs. LF diet (Fig. 3a). We next characterized these 2 DEG lists, relying on GO over-representation tests, filtering out GO terms supported by less than 3 genes and considering a *p*-value adjusted with the Benjamini-Hochberg correction ≤5%. These filters suggested functional pathways that were strongly affected by diet (Fig. 3b).

Regarding the 298 down-regulated genes, three GO terms were over-represented, and these genes were
<figure><img src="image_12.png" /></figure>

related to glucose and fatty acid (FA) metabolism. We therefore performed a finer-grained analysis, focusing on the expression of key regulators and enzymes involved in these pathways (Fig. 3c). Several genes regulating glucose homeostasis were significantly down-regulated in the HF diet vs. the LF diet: HKDC1, encoding an isoform of hexokinase involved in the first step of glucose use in cells; UGP2, PGM1 and PGM2, involved in glycogenesis; and PDHB and DLAT, encoding subunits of pyruvate dehydrogenase, which catalyzes the conversion of pyruvate to acetyl coenzyme A (Fig. 3c). At the metabolite level, we confirmed that glycogenesis was impaired by diet changes, with a significantly lower amount of glycogen in the livers of chickens fed HF vs. LF diets (p-value ≤0.0001, Fig. 3d). Additionally, numerous genes encoding key enzymes in FA and TG synthesis pathways were differentially expressed between the diets: ACSL3, ACSL5 and ACSL6,

involved in FA activation; ME1, ACLY, ACACA, FASN, SCD, ELOVL6 and ELOVL3, involved in de novo fatty acid synthesis; and GPAT (alias GPAM), AGPAT2, DGAT2, PNPLA3, LPIN1, PLIN2, ACSBG2 and MTTP, involved in TG synthesis, lipid storage, and secretion. We confirmed the down-regulation of most of these genes by HF diet using RT-qPCR (Additional file 4). Among the set of 298 down-regulated genes, the gene most repressed by the HF diet was SCD (7-fold change), which encodes the rate-limiting enzyme of MUFA biosynthesis that converts the saturated fatty acid C18:0 into mono-unsaturated C18:1. Changes in the expression of other genes related to FA and TG synthesis, while significant, were more subtle (1.65-fold change on average, Fig. 3c, right).

Of the 166 up-regulated genes in HF diet vs. LF diet, “carnitine transport” was the only over-represented GO term, with *CPT1A* being the most highly induced gene
(logFC = 2). We further observed a significant correlation (r = 0.43, *p*-value ≤0.05) between its expression in the liver and in PBMCs (Fig. 3e), which was confirmed by RT-qPCR (Additional file 4).

Relationships between hepatic lipid-associated entities observed at the transcriptomic, enzymatic and metabolic levels

The previous analysis highlighted dietary-associated molecular variations in expression levels of genes related

to FA synthesis in liver. However, the lipid content in the liver and peripheral tissues, such as muscle and abdominal fat, did not differ between diets (Fig. 4a), suggesting either a disconnection between mRNA level and lipogenic enzymes activities or a genuine repression of lipogenesis concomitant with a direct dietary FA deposition in different tissues when chickens were fed HF diets. Because some fatty acids (e.g., C16:0; C18:1) were more specifically issued from de novo FA synthesis while essential FAs (e.g., C18:2 and C18:3) were derived from

a Total lipid content

<figure><img src="image_13.png" /></figure>

b MFA scatter plot representing the 46 birds

<figure><img src="image_14.png" /></figure>

c Projection of PCA original dimensions of the distinct datasets in MFA dimension

<figure><img src="image_15.png" /></figure>

d Contribution to the MFA dimension 1 of the top variables (r>0.75) from each dataset

<figure><img src="image_16.png" /></figure>

<table><tr><td>1. KCNAB2</td><td>11. ACSBG2</td><td>21.LOC419500</td><td>31.SEC31B</td></tr><tr><td>2. SCD</td><td>12. SSPN</td><td>22. VMP1</td><td>32. ACSL5</td></tr><tr><td>3. RIMBP2</td><td>13. WDPCP</td><td>23.LOC10085787</td><td>33. LOC100857899</td></tr><tr><td>4. CEBPA</td><td>14. MAPK6</td><td>24. UGP2</td><td>34. LOC768701</td></tr><tr><td>5. DUSP14</td><td>15. CCDC37</td><td>25. HMGCL</td><td>35. ESCO1</td></tr><tr><td>6. FASN</td><td>16. CDKN2B</td><td>26. THRSP</td><td>36. XKRX</td></tr><tr><td>7. TADA2A</td><td>17. DLAT</td><td>27. RAB11FIP4</td><td>37. LPIN1</td></tr><tr><td>8. ACSL6</td><td>18. CCNG2</td><td>28. ACACA</td><td>38. BTG2</td></tr><tr><td>9.C19H17orf78</td><td>19. MTTP</td><td>29. AGPAT2</td><td>39. LRRC8C</td></tr><tr><td>10. MFSD2A</td><td>20. PLIN2</td><td>30. ELOVL6</td><td></td></tr></table>

e

<figure><img src="image_17.png" /></figure>

f

<figure><img src="image_18.png" /></figure>

g Lipids and lipoproteins in plasma

LF
HF

<figure><img src="image_19.png" /></figure>

<figure><img src="image_20.png" /></figure>

**Fig. 4** Hepatic fatty acid biosynthesis and secretion was the major metabolism altered in response to the dietary lipid source. **a** Lipid content in three tissues (% of tissue weight). **b, c** and **d** MFA representations related to individuals (**B**) and variables (**C** and **D**). Blue color is related to transcriptomic data and red color to metabolic data. In **D**, genes in bold blue are known to be involved in FA and TG synthesis storage; grey genes have unknown function. **e** Effect of HF and LF diets on the three FA classes (in % of total FA). **SFA**: saturated FA (C14:0 + C16:0 + C18:0), **MUFA**: monounsaturated FA (MUFA (C16:1 + C18:1), **PUFA**: n-6 and n-3 polyunsaturated FA. **n** = 24 per diet (no effect of lines). **f** Effect of HF and LF diets on the activity of fatty acid synthase (FASN) enzyme and correlation between this activity and the FASN expression. **n** = 24 per diet. **g** Plasmatic cholesterol (mg/l), triglyceride (mg/l) and lipoproteins. **\*\***: *p*-value ≤0.01, **\*\*\***: *p*-value ≤0.001, **NS**: No Significant
dietary lipid deposition, we next integrated the mo-
lecular data related to the 465 genes modulated by
diet in liver with hepatic FA composition and
plasma metabolites using a multiple factor analysis
(MFA, see methods). The first dimension of the
MFA divided the birds according to diet and ex-
plained a high proportion of total variation in traits
of interest between the two diets (Fig. 4b). We sub-
sequently determined the variables contributing the
most to this dimension. We observed that the first
dimension of each PCA performed on each dataset
(i.e., transcriptome and metabolites) strongly con-
tributed to the first dimension of MFA (Fig. 4c). We
then extracted variables contributing the most to the
first MFA dimension (|r| > 0.75, p-value< 0.001).
Among the 25 metabolites, 7 were selected corre-
sponding to PUFAs in the n-6 and n-3 families
(C18:2, C20:4, C22:5 and C22:6) and SFAs and
MUFAs (C16:0, C16:1 and C18:1); PUFAs were nega-
tive contributors to the first MFA dimension, con-
trary to MUFAs and SFAs, which contributed
collinearly with LF diet (Fig. 4d). Among the 465
DEGs, 39 genes were selected as contributing the
most to the first dimension of MFA collinearly with
LF diet. Among these genes, five encode unknown
proteins, and 17 (50%) are related to FA and TG
synthesis or glucose metabolism (Fig. 4d, genes in
blue gold). In particular, FASN contributed to the
first dimension of MFA and LF diet. Interestingly,
we also observed an increase in FASN activity in the
livers of chickens fed the HF diet (Fig. 4e left), ac-
tivity significantly correlated with FASN expression
(Fig. 4e right). Conversely, the multiple factor ana-
lysis did not reveal genes whose expression changes
are collinear with variation of PUFA percentage,
suggesting an absence of the transcriptomic regula-
tion of PUFA storage in liver in this situation.

Because de novo synthesis of FA is one of the first
steps before lipid secretion and exportation from
liver to peripheral tissues, we also studied SFA,
MUFA and PUFA proportions in muscle and abdom-
inal adipose tissues. We observed a higher propor-
tion of PUFA in chickens fed the HF diet and higher
proportions of SFA and MUFA in the muscle and
adipose tissues of those fed LF diets, which paral-
leled the variations observed in the liver (Fig. 4f).
Because there was no transcriptomic change in
muscle and adipose tissue associated with diet, these
changes in the FA profile were probably related to
metabolic rather than transcriptional changes. Con-
sistently, circulating concentration of LDL lipopro-
teins was significantly increased in plasma of LF diet
vs. HF diet, together with plasma cholesterol con-
centration (Fig. 4g), suggesting a reverse transport of

cholesterol to liver after fatty acid uptake by the per-
ipheral tissues.

Transcription factors and de novo lipogenesis regulation
upon starch substitution

Among the 464 DEGs in the liver, we identified 15
transcription factors, nuclear hormones or transcrip-
tional co-activators (see methods). All of these genes,
except ESR2, were down-regulated in HF vs. LF diet,
namely, SREBF1 (alias SREBP1), PPARD, CEBPA,
TRIP11, TADA2 (alias ADA2a), NRIP1, JUN, ATF3,
HIF1A, BACH1, KAT2B (alias P300/CBP or PCAF),
LIMD1, HHEX and FOXK2, (Fig. 5a and b). Other
transcription factors with well-known roles in lipogen-
esis regulation, such NR1H3 (alias LXRA) and
MLXIPL (alias ChREBP) [26–30], were not found in
the list of DEG between HF and LF diets. Using RT-
qPCR, we confirmed that NR1H3 and MLXIPL were
not DE between the two diets, contrary to SREBF1
(Fig. 5b). Moreover, we observed that SREBF1 expres-
sion was highly correlated (r > 0.75, p ≤ 0.001) to the
expression levels of the 3 genes encoding the main en-
zymes of de novo FA synthesis (e.g., ACACA, FASN
and SCD (Fig. 5c)) and to the expression of ACLY,
which encodes the ATP citrate lyase, the primary
enzyme responsible for the synthesis of cytosolic
acetyl-CoA, substrate of ACACA. Notably, significant
correlations between ACACA, FASN and SCD gene
expression and PPARD or JUN were also observed
(0.48 to 0.51 for PPARD, 0.54 to 0.62 for JUN, all with
p ≤ 0.001 Fig. 5c). However, correlations between lipo-
genic gene expression and PPARD or JUN are lower
than those observed with SREBF1. Finally, the expres-
sion levels of NR1H3 and MLXIPL were not signifi-
cantly correlated with the expression levels of the
three genes encoding lipogenic enzymes (e.g., r = 0.07
and 0.22 for SCD, 0.02 and 0.3 for FASN and 0.12 and
0.32 for ACACA, respectively).

Focus on a genomic region involved in the adaptation to
starch substitution

For the 464 DEGs, we searched for co-localized
genes on the genome, hypothesizing that co-localized
genes might be co-regulated. This search revealed a
gene cluster composed successively of ACACA,
C19H17orf78 (alias C17ORF78 or Gm11437 in
mouse), TADA2A and DUSP14 (Fig. 6a) on chromo-
some 19. These genes were all significantly down-
regulated in chickens fed the HF diet (p-value ≤0.05)
in contrast with more distant genes, such as SYNRG
or ATFF (Fig. 6b). Interestingly, the expression of
these 4 genes was highly correlated (r = 0.82, 0.90
and 0.79, p-value< 0.001, between ACACA,
<figure><img src="image_21.png" /><figcaption>b</figcaption></figure>

<figure><img src="image_22.png" /><figcaption>c</figcaption></figure>

<figure><img src="image_23.png" /></figure>

**Fig. 5** Expression of DE transcription factors, nuclear hormones or transcriptional co-activators in liver of chickens fed HL or LF diets. **a** and **b** Differences in expression levels between HF and LF diets were significant for all genes except *NR1H3* and *MLXIPL*. \*\*\*: *p*-value ≤0.001, \*\*: *p*-value ≤0.01, \*: *p*-value ≤0.05, NS: No Significant. C. Correlations between SREBF1, JUN or PPARD with different DE genes encoding key lipogenic enzymes

C19H17orf78 or DUSP14 and TADA2A taken as a
reference because of its central position, Fig. 6c).
Such high correlations were also found in another
chicken experimental design, corresponding to layers
and females (Fig. 6c, Additional file 5). To explore
these loci throughout life evolution, we performed a
similar analysis on mouse gene expression data from vari-
ous experimental designs (http://www.ncbi.nlm.nih.-
gov/gds). Expression levels of TADA2A, ACACA and
DUSP14 were not correlated in the liver of NMR1 mice fed
different diets for 2 weeks (GDS3232 dataset, n = 22 from
Somel et al. [31]) (Fig. 6d left). However, for the same data-
set, the correlation in expression of these genes was signifi-
cant in the brain (Fig. 6d right). The absence of a
correlation between these genes in mice liver was further
confirmed in another dataset related to C57BL/6 J mice fed

a high-fat diet or a normal diet for up to 24 weeks
(GDS6248 dataset, n = 51, [32]). Finally, Fig. 6e depicts the
genes highly correlated with TADA2A (r > = 0.8) among
the 298 down-regulated genes in chickens fed the HF diet.
We identified 21 correlated genes with significant enrich-
ment in genes related to lipid metabolism: 11 genes among
the 21 TADA2A-correlated genes vs. Fifty six genes among
the 298 down-regulated genes.

Discussion

The liver transcriptome but not the muscle or adipose transcriptome contributed to the adaptation of birds to dietary starch substitution with fat and fiber

The primary objective of this study was to investigate the
molecular mechanisms build up by tissues when chickens
face changes in their dietary energy source. We first
<figure><img src="image_24.png" /><figcaption>**Fig. 6** A co-localized and co-expressed gene set containing ACACA and TADA2A. a Syntenic region conserved between chicken, human and mouse. b Hepatic expression of the syntenic genes in the two diets and genotypes for male broiler chickens. c Correlation between TADA2A hepatic expression (taken as reference) and hepatic expression of other co-localized genes in two chicken experimental designs. Top: male broilers analyzed in this study (n = 48); bottom: female layers analyzed by RNA-Seq (n = 40). Rpkm normalized expression are available in the Additional file 5. d Expression in liver (Liv) and brain (Br) of C57BL/6 J mice (n = 22) (GDS3232 in GEO profiles [31]). e Circle plot depicting the correlation between TADA2A and the 298 down-regulated genes in HF diet: red edges indicate genes which expressions are highly correlated to TADA2A expression (r > =0.8). Red names indicate genes involved in lipid metabolism. Correlations in bold in the Figure (r > 0.7) are highly significant with a p-value ≤0.001</figcaption></figure>

observed that liver weight was impacted by a change in diet, with a significant reduction in chickens fed the HF diet vs. the LF diet. Changes in the liver/body weight ratio have often been reported in response to various stresses and stimuli, e.g., in the case of drug administration [33], infectious environment [34], or changes in diet composition [35, 36]. This reduction in liver weight in chickens fed the HF diet may reflect a lower storage of glycogen, as previously observed [36]. Moreover, we also provided new evidence for the overall repression of expression: among the 465 hepatic DEGs, approximately 300 genes were down-regulated in chickens fed the HF vs. LF diets. Finally, whereas a similar number of protein-coding genes were expressed in the four studied tissues, including the muscle, abdominal fat and blood cells, only the liver presented DEGs in response to the dietary changes. Overall, the present study suggests that liver is the keystone organ in metabolic adaptation upon dietary starch substitution with fat and fiber in chicken.

## The main effect of starch substitution with dietary fat and fiber was the reduction in hepatic de novo fatty acid synthesis

The present observations at the transcriptomic, enzymatic and metabolic levels highlight two different types of pathways that were triggered either from the dietary starch or dietary lipids. In both cases, all the action occurred in the liver. In the case of the high-starch LF diet, carbohydrates were used for de novo hepatic FA synthesis, which provides fatty acids that were then secreted from the liver to peripheral tissues through lipoproteins. In the case of the HF diet, dietary fatty acids enriched in n-3 and n-6 PUFA (diet: 56% against 33% of MUFA and 12% of SFA) were directly stored in the different tissues.

These observations, suggesting a direct deposition of FA for chicken fed an HF diet, are further supported by the higher amount of n-3 and n-6 PUFA vs. MUFA+SFA observed in liver, adipose tissue and muscle, since C18:2 and C18:3 cannot be synthesized by animals.
Interestingly, no transcriptional adaptation is required for such deposition, since no DEG was observed in adipose tissue or muscle.

The higher de novo lipogenesis, TG synthesis and export from liver to peripheral tissues in LF were supported at different levels. First, at the metabolic level, we observed an increase in de novo hepatic SFA and MUFA amounts; an increase in SFA and MUFA amounts in muscle and adipose tissue disconnected from any in situ de novo FA synthesis; and finally, an increase in plasmatic low-density lipoproteins (LDL) and total cholesterol, whereas very-low-density lipoprotein particles (VLDL) and total TG were not affected. Indeed, endogenous FA constituting TGs are secreted into the blood in the core of VLDL and then transformed in IDL after liberation of free FA and then in LDL richer in cholesterol. Second, at the enzymatic level, we observed an increase in the hepatic FASN activity. Third, at the transcriptomic level, we highlighted the up-regulation of several genes encoding major enzymes catalyzing steps in the FA synthesis process (i.e., ACACA, FASN, SCD, ELOVL6, ACLY, ME1); FA activation and transport

(ACSL3, ACSL5, ACSL6, MFDS2A, FABP7); and TG synthesis, remodeling and packing to VLDL for export to peripheral organs (GPAT1, AGPAT2, LPIN1, DGAT2, PNPLA3, LIPG, PLIN2, MTTP) in the liver of chickens fed the HF diet (Fig. 7). This large number of up-regulated genes explains why GO terms related to FA synthesis and TG synthesis were over-represented in the present analysis, despite the use of *p*-values corrected for multiple testing, which is rare enough to be mentioned. Regarding enzymes involved in TG synthesis, they are characterized by different isoforms (e.g., GPAT1–3, AGPAT1–4 and DGAT1–2). Notably, GPAT1, AGPAT2 and DGAT2, which were shown to be regulated at the transcriptional level in the present study, have been previously reported as the most active isoforms according to a meta-analysis on transgenic mice for these different isoforms [28]. Moreover, in the present study, the top-regulated gene by LF diet encodes SCD, which further supports the well-established pivotal role of this enzyme in FA synthesis and TG secretion. First, SCD catalyzes the conversion of SFA to MUFA (oleyl-CoA) through the

<figure><img src="image_25.png" /><figcaption>**Fig. 7** Putative mechanisms explaining hepatic impact of PUFA on genes encoding lipogenic enzymes and SREBF1 and NR1H3 transcription factors in HF diet vs. LF diet. 1- [46, 47]. 2-[48–50]. 3- [51, 52]. 4- [53]. 5- [54, 60, 102]. 6- [60, 102]. 7- [103, 104]. 8- [105]. 9- [106]. 10: [56, 57, 107]</figcaption></figure>
initial desaturation of FA. Second, it enhances FA incorporation into TG, since the oleyl-CoA (C18:1 n-9) is the preferential acyl-CoA incorporated in lysophosphatidic acid by DGAT2 at the sn-2 position [37]. As expected, as an upstream pathway of lipogenesis, glycolysis is switched on by the LF diet, as illustrated by the activation of HKDC1, a gene encoding a newly characterized hexokinase isoform [38, 39] catalyzing the first step of glycolysis. PDHB and DLAT genes were also activated, and these genes encode the pyruvate dehydrogenase complex, which provides the substrate linking glycolysis, tricarboxylic acid (TCA) cycle and de novo lipogenesis [40]. This complex has a pivotal position in fueling crosstalk since it catalyzes the mitochondrial conversion of pyruvate – provided by glycolysis – into acetyl-CoA used in TCA cycle as a citrate source. This compound can subsequently exit the TCA and be further converted into acetyl-CoA through a reaction involving ACLY, which was also transcriptionally up-regulated in LF diet (Fig. 7). As expected, dietary carbohydrates provided by the LF diet were used not only in de novo lipogenesis but also in glycogenesis. Indeed, the expression of the genes PGM1, PGM2 and UGP2 – involved in glycogen storage – and hepatic glycogen concentration were increased in chickens fed the LF diet. These transcriptomic and lipidomic observations in chicken liver were consistent with expected changes due to diet composition with less starch in an HF diet; moreover, not only the decrease in glucose derived from starch but also the concomitant increase in dietary lipids in the form of PUFA could be responsible for such changes. Indeed, various studies have reported an inhibition of de novo hepatic FA synthesis by n-3 and/or n-6 PUFA [41–43]. Moreover, among the three metabolic tissues analyzed here, such inhibition occurs solely in the liver, which further emphasizes the established central role this organ plays in lipogenesis in birds [44, 45].

The entire set of genes encoding enzymes involved in de novo lipogenesis was down-regulated in the HF diet. Therefore, we further focused on lipogenic regulators, especially on the three major and well-described hepatic lipogenic transcription factors SREBF1 (alias SREBP1) [26], NR1H3 (alias LXRA) [27, 28] and MLXIPL (alias ChREBP) [29, 30]. Among these 3 genes, only SREBF1 was repressed in LF vs. HF diet, and its expression was highly correlated with the expression of genes encoding the key lipogenic enzymes. As previously reported in mammals [46–54], most of the genes encoding enzymes involved in FA and TG synthesis are direct targets of SREBF1 (e.g., ACLY, ACACA, FASN, ELOVL6, SCD, PNPLA3), as illustrated in Fig. 7, which is further corroborated by the present observations. The down-

regulation of SREBF1 and lipogenic genes in chickens fed the HF diet is likely related to the dietary PUFAs in the HF diet. Indeed, dietary PUFAs are known to inhibit SREBF1 activity through several mechanisms. First, PUFAs inhibit SREBF1 nuclear uptake (SREBF1 has to be cleaved to enter the nucleus and be active) – even if the mechanism is not yet elucidated; this reduction is mRNA level independent [55]. Second, it has been reported that SREBF1 transcript levels are influenced by PUFA concentration, as observed in the present model [55, 56]. Additional studies further describe a critical role of NR1H3 in the PUFA-mediated down-regulation of SREBF1 mRNA levels [56, 57], indicating that SREBF1 transcripts are inhibited by PUFAs by an antagonizing ligand-dependent activation of *NR1H3*. Nevertheless, there are no reports of a direct effect of PUFA on NR1H3 transcripts so far. The present observations on lipogenic genes and the SREBF1 and NR1H3 transcript regulation observed between HF vs. LF diets support the hypothesis that such regulation may occur in chickens, as summarized in Fig. 7. The well-established ability of dietary PUFAs to decrease the de novo FA synthesis and TG secretion in the livers of mammals was also observed in chicken liver and would involve, at least to some extent, SREBP1 repression, which likely depends on NR1H3 protein. In contrast, the MLXIPL transcription factor does not seem to be involved in the response to PUFAs in the HF diet in chickens. First, the expression of MLXIPL transcript was not decreased in response to the HF diet, while PUFAs suppress MLXIPL activity both by impairing its translocation from the cytosol to the nucleus and by increasing MLXIPL transcript degradation in mammals [30]. Second, MLXIPL plays a pivotal role in the induction of both glycolytic and lipogenic genes by carbohydrate [29, 58]. This is achieved through the binding of this protein to the ChoRE sites in promoters of its target genes involved in either lipogenesis (ACACA, FASN and PNPLA3) [59, 60] or glycolysis (PK) [61, 62]. We did not observe any repression of *PK* transcription, but we did observe a decrease in ACACA, FASN and PNPLA3 transcript levels, likely related to the SREBF1 activity.

The implication of SREBF1 and likely NR1H3 as major transcription factors of de novo lipogenesis regulation does not exclude the putative implication of other transcription factors. For example, PPARD and JUN could play an important role in this regulation. Among the PPAR nuclear receptor family, PPARA and PPARG are well described to activate hepatic FA catabolism as well as adipocytic differentiation and lipid storage. Conversely, PPARD is expressed in various tissues [63] and has multiple but less-characterized functions (for review, [64]). However, several studies reported its role in the regulation of hepatic lipogenesis. Thus, Lee et al. [65]
described transcriptional changes occurring in liver, adipocytes and muscle for *db/db* mice upon treatment with a PPARD antagonist (GW501516) and highlighted that the hepatic transcriptome was the most responsive, exhibiting an up-regulation of ME1, ACLY, ACACA, FASN, ELOVL6 and GPAT involved in de novo lipogenesis and TG synthesis. More recently, Liu et al. [66, 67] showed that PPARD enhances the use of glucose for glycogen storage and lipogenesis in liver and controls diurnal expression of lipogenic genes in the light-dark/feeding cycle. Altogether, these studies suggest a potential role for PPARD in regulating the differences in lipogenesis we observed between the two diets. JUN represents a potential regulator driving differences in lipogenesis observed in the present study. Indeed, this oncogene is well characterized as playing roles in cell proliferation, cell survival, apoptosis and tumorigenesis [68, 69] and has recently been described as being involved in lipid accumulation by direct binding to SREBF1 promoter (Guo et al. [70]). Interestingly, this study also reports that JUN knockdown in Hep1-6 cells reduced SREBF1 and FASN protein levels and lipid storage. Notably, in the present study, correlations were observed between ACACA, FASN and SCD. Taken together, these results and reports suggest a major role for SREBF1 and potential roles for PPARD and JUN in HF diet-mediated lipogenesis repression.

### CPT1A mRNA, the only marker of high-fat diet in blood cells

Focusing on the liver, we noted - upon an HF diet - an activation of *CPT1A* expression, a gene encoding the carnitine palmitoyltransferase 1 [71] that is the β-oxidation rate limiting enzyme for the uptake of long chain fatty acids into the mitochondria. This enzyme ensures the transport across the mitochondrial inner membrane of the long-chain fatty acyl-CoA before β-oxidation. This enzyme is involved in the cross-talk between β-oxidation and lipogenesis, since it is allosterically inhibited by the malonyl-CoA, which is the product of the ACACA activity and the substrate of the de novo lipogenesis. The present results corroborate the key role of *CPT1A* in this cross talk. Strikingly, microarray analysis did not identify any DEG involved in mitochondrial β-oxidation such as *ACADL*, *ACADS* or *EHHADH*, these latter reported as being co-expressed with *CPT1A* in various situations involving β-oxidation such as fasting [12, 42]. Similarly, genes coding peroxisomal β-oxidation enzymes such as *ACOX1-3* that is involved in the PUFA β-oxidation [72], were also not found to be differentially expressed in our model. These last results suggest that the regulation of FA import into mitochondria is the key step for the β-oxidation regulation. In addition, *CPT1A* was the only gene differentially expressed between diets in blood, more precisely in

PBMCs. This result is consistent with the observation reported in a recent study using high-fat diet-induced obese rodents [73]. These authors showed an increase in *CPT1A* expression in blood of rats fed an HF diet, further confirmed in the blood of mice fed an HF diet. Another study using pigs fed an high fat-high fiber diet shows similar results [74]. Taken together, these results suggest that *CPT1A* mRNA blood level can be used as a biomarker of high-fat diet in chicken, pigs, rats and mice.

### TADA2A and other co-localized genes would be potential new actor of lipogenesis

On chromosome 19, we described a highly conserved cluster of four co-expressed neighboring genes: ACACA, TADA2A, C19H17orf78 and DUSP14. In several species (sheep, rats, mice, cattle and humans), ACACA and TADA2 genes are divergently oriented onto the genome and share a GC-rich bidirectional promoter, which explains their simultaneous expression [75, 76]. Notably, in chickens, four transcripts are described for ACACA in the Ensembl database (Gal-gal 5.0), and a single promoter has been characterized thus far [50, 77], while 23 transcripts and many alternative tissue-specific promoters are described in human genome annotation [78]. In this study, we showed that the expression of these 4 genes located on this genomic locus in the liver is highly correlated in different chicken strains, while such a correlation was not found in mouse liver but was observed in the brain. This latter observation in mice is consistent with those of studies reporting a higher expression of ACACA alternative transcripts derived from the bidirectional promoter shared with the divergently oriented TADA2A gene in mouse brains [75, 78]. While ACACA is a key rate-limiting enzyme involved in FA biosynthesis and plays a pivotal role in cellular energy homeostasis, the biological link between the three other genes and energy regulation is not clear. C19H17orf78 is the ortholog of human C17ORF78 and mouse Gm11437. It was referenced in the Ensembl database V76 (August 2014) and is still referenced in the current NCBI gene database but is absent from Ensembl V87 (Galgal 5.0). The role of this gene is still unknown. DUSP14 belongs to the dual-specificity phosphatase family that includes critical regulators for many biological processes such as T-cell development, immune regulation and tumorigenesis [79, 80]. DUSPs are protein phosphatases catalyzing the dephosphorylation of phosphothreonine, phosphoserine, and phosphotyrosine residues from its own substrates. No association between this gene and hepatic lipids has been reported thus far. TADA2A (alias ADA2A, Transcriptional Adaptor 2A) encodes a subunit of the ATAC (Ada-Two-A-containing) protein complex belonging to the histone acetyl transferase (HAT) complexes, recently renamed the lysine acetyl
transferase (KAT) complex. The biological function of KAT complexes is not fully understood, but it plays a crucial role in eukaryotes by regulating chromatin architecture and locus-specific transcription [81–83]. The present study suggests that these three genes— C17ORF78, DUSP14 and, more specifically the gene en- coding TADA2A transactivator of the KAT complex—could be involved in hepatic lipogenesis. First, TADA2A shares its promoter with ACACA that encodes a key enzyme from lipogenesis, both being co- expressed in different animal model. Second, the four co-localized genes strongly contributed to dimension 1 of the multifactorial analysis, a dimension that clearly splits de novo-synthesized FAs and dietary PUFAs. Third, the genes most highly correlated with TADA2A (r > 0.8) are significantly enriched in lipid-related func- tions (50% of the 21 genes): ACACA of course but also FASN, SCD and ELOVL6, encoding the 4 key lipogenic enzymes; DLAT, encoding an enzyme that catalyzes the conversion of pyruvate to acetyl-CoA; and MTTP, which is involved in the TG secretion. Interestingly, we found other genes whose expression was highly corre- lated with the expression of TADA2A and related to lipid metabolism, even if this correlation was not pre- cisely reported for liver so far. MFSD2A is involved in n-3 fatty acid docosahexanoic acid (DHA) transport and in maintaining the integrity of the blood-brain bar- rier [84, 85]. The role of MFSD2A in hepatocytes re- mains unclear, even if different reports have shown a role in body lipid metabolism [86, 87]. ABHD5 is a co- activator of PNPLA2 and affects PNPLA3 activity in re- lation to lipid droplet remodeling [88]. NPC1 is a membrane protein that mediates intracellular sterol trans- port in late endosomes and lysosomes and participates in cellular cholesterol homeostasis and distribution in differ- ent organelles [89]. THRSP (alias SPOT14) was discov- ered three decades ago, and numerous studies have reported a role in de novo lipogenesis. Indeed, the THRSP expression level in a given tissue is correlated with its abil- ity to synthesize lipids (e.g., white adipose tissue, brown adipose tissue, or liver) [90–95]. SPOT14 expression is induced by the thyroid hormone [96] and the constitutive androstane receptor (NR1I3) [97]. More recently, Wu et al. [98] showed that SPOT14 is a direct target of the key lipogenic SREBF1 transcription factor. However, the biochemical mechanism linking SPOT14 to de novo lipo- genesis remains unclear. Finally, SEC31B encodes a subunit of the coat protein complex II (COPII) involved in the ER-Golgi transport [99]. Recently, Han et al. showed that SREBF1 is carried from the endoplasmic reticulum to the Golgi in a COPII-dependent manner and then shuttled to the nucleus to induce lipogenic gene expression in response to feeding [100]. According to these results, TADA2A is likely to play a role in the

regulation of lipid metabolism. Interestingly, another tran-
scription activator – KAT2B – is also down-regulated in
chickens fed an LF diet and belongs to the same HAT/
KAT complex family as TADA2A. KAT2N forms a multi-
protein KAT complex with KAT2A (alias hGCN5). In
addition to acetyl transferase activity toward the histone
proteins of these HAT/KAT complexes involving
TADA2A or KAT2B, a growing number of non-histone
substrates have been identified (for review, see [82, 101].
Taken together, these results and reports suggest a new
diet-induced regulatory mechanism for lipid metabolism
based on lysine acetylation of histone and/or non-histone
proteins through HAT/KAT complex family.

Conclusions

The present study shows that two different types of path-
ways are activated depending on the nature of the energy
supply, e.g., carbohydrates or lipids. The liver orchestrates
this adaptation to lipid-rich diets by a decrease in de novo
lipogenesis and TG secretion, through fine-tuned tran-
scriptional regulation. We highlight a hypothesis concern-
ing the potential mechanisms underlying these
observations, particularly a likely decisive role of NR1H3/
PUFA-mediated SREBF1 repression and the potential im-
plication of other transcription factors, such as PPARD,
JUN or TADA2A and KAT2B, in lysine acetyl transferase
via the KAT complexes.

Additional files

**Additional file 1:** Composition of diets. (XLSX 34 kb)

**Additional file 2:** Exploration by Principal Component Analysis (PCA) of transcriptomic data (all expressed genes) for each tissue to identify outlier samples. Out of 48, 46, 48 and 44 arrays for liver, adipose, muscle and PBMC respectively, 2, 1, 2 and 1 outlier microarrays were identified by PCA using all the expressed genes. For muscle and PBMC, an additional sample was removed because of an abnormal high number of Agilent-flagged spots or an abnormal background distribution on the array. (PPTX 173 kb)

**Additional file 3:** Primers used for DEG validation by RT-qPCR. (XLSX 13 kb)

**Additional file 4** DEG in liver between the two diets and some features. ArrayFC and ArrayPvalue provide the HF/LF expression ratio and the p-value adjusted for the multiple test obtained with the microarray technology. qPCRFC and qPCR_Pvalue provide the HF/LF expression ratio and the p-value obtained with the RT-qPCR technology. (XLSX 70 kb)

**Additional file 5:** Hepatic expression of ACACA, C19H17orf78, DUSP14, AATF and SYNRG for female layers (n = 40). RNAseq data are normalized by the classical rpkm method (Chickstress Project – ANR-13-ADAP). (XLSX 54 kb)

Abbreviations

ACACA: Acetyl-CoA carboxylase; ACLY: ATP citrate lyase; ACSBG2: Acyl-CoA synthetase bubblegum family member 2; ACSL3, ACSL5 and ACSL6: Acyl-CoA synthetases; AGPAT: 1-acylglycerol-3-phosphate O-acyltransferase; ATF: Activating transcription factor 3; BACH1: BTB Domain And CNC Homolog 1; CEBPA: CCAAT/enhancer-binding protein alpha;

ChREBP: Carbohydrate response element binding protein; COPII: Coat Complex Component; CPT1A: Carnitine palmitoyltransferase 1A (liver type); DEG: Differentially expressed gene; DEP: Differentially expressed probe;
DGAT: Diacylglycerol acyltransferase; DLAT: Dihydrolipoamide S-Acetyltransferase; DUSP14: Dual specificity phosphatase 14;

ELOVL: Elongation of very-long chain; ESR2: Estrogen receptor 2; FA: Fatty acid; FABP: Fatty acid binding protein; FASN: Fatty acid synthase;

FOXK2: Forkhead Box K2; GO: Gene ontology; GPAT: Glycerol-3-phosphate acyltransferase; HF: Low-starch high-fat high-fiber diet;

HHEX: Hematopoietically expressed homeobox; HIF1A: Hypoxia-inducible factor-1; HKDC1: Hexokinase domain containing 1; JUN: Jun proto-oncogene, AP-1 or transcription factor subunit; KAT2B: Lysine acetyltransferase 2B;

LF: High-starch low-fat low-fiber diet; LIMD1: LIM domains containing 1;

LPIN1 and PLIN2: Lipin 1 and 2; LXR: Liver X receptor; ME1: Malic enzyme;

MFA: Multiple factor analysis; MFSD2A: Major Facilitator superfamily domain containing 2A; MLXIPL: MLX Interacting protein like (alias ChREBP);

MTTP: Microsomal triglyceride transfer protein; MUFA: Monounsaturated fatty acids; NPC1: NPC Intracellular cholesterol transporter 1; NR1H3 (alias LXRA): Nuclear receptor subfamily 1 group H member 3 (alias Liver X Nuclear Receptor alpha; NRIP1: Nuclear receptor interacting protein 1; PCA: Principal component analysis; PCAF: Alias P300/CBP associated factor; PCR: Polymerase

chain reaction; PDHB: Pyruvate dehydrogenase (Lipoamide) beta; PGM1 and PGM2: Phosphoglucomutase 1 and 2; PNPLA3: Patatin Like phospholipase domain containing 3; PPAR: Peroxisome proliferator activated receptor; PPARD: Peroxisome proliferator-activated receptor delta;

PUFA: Polyunsaturated fatty acids; SCD: Stearoyl-CoA desaturase;

SEC31B: SEC31 homolog B; SFA: Saturated fatty acids; SREBF1: Sterol regulatory element binding protein-1; SREBF1: Sterol regulatory element-binding transcription factor 1; TADA2A: Transcriptional adaptor 2A;

TG: Triglyceride; THRSP: Thyroid hormone responsive; TRIP11: Thyroid receptor-interacting protein 11; UGP2: UDP-Glucose pyrophosphorylase 2

### Acknowledgements

The authors thank the staff of the INRA experimental poultry unit (UE1295 PEAT, Nouzilly, France) for producing and rearing animals and the technicians of the research units for measurements on birds and sample collection. The authors also thank F. Martins (GeT GenoToul platform, Toulouse, France) for his technical contributions on Fluidigm data production. English was improved by Nature Research Editing Service from Springer Nature (http://authorservices.springernature.com/language-editing/).

### Funding

This project received financial support from French National Agency of Research (FatInteger project, ANR-11-SVS7) and also used data from the ChickStress Project (ANR-13-ADAP).

### Availability of data and materials

The 178 microarrays are MIAME compliant and available in Gene Expression Omnibus (GEO) through GEO Series accession number GSE104042 and platform number GPL19630.

### Authors' contributions

MD, EB, CD, FG and SL: conceived the study and the experimental design. EB, CD, SA, FG, PFR, CB, SMC, EL, AC, MD and SL participated to the set-up of the experimental design, and to sample collection; ML: defined the diet. CD, and AL: generated microarray data; CD, MB and JM generated Fluidigm data and carried out analysis. EB and FG provided measures of traits, metabolites and FASN enzymatic activity. MA, CHA, DC, MHB, YB and SL: conceived and/or participated to the statistical analyses; EB, CD, FG, AC, MD and SL interpreted the data; SL coordinated the study; CD and SL drafted the manuscript. All authors helped to draft the manuscript and read and approved the final version.

### Ethics approval and consent to participate

All experiments were conducted following the French National Guidelines for the care and use of animals in research edited by the French Ministries of Higher Education and Scientific Research, and of Agriculture and Fisheries http://ethique.ipbs.fr/charteexpeanimale.pdf. The protocol was also approved by the local Ethics Committee of Val de Loire, France (authorization to experiment on living animals n°7740, 30/03/2012).

### Consent for publication

"Not applicable"

### Competing interests

The authors declare that they have competing interests with Elisabeth Lebihan as a member of the editorial board of BMC genomics journal.

### Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

### Author details

¹Pegase, INRA, Agrocampus Ouest, 35042 Rennes, France. ²Ura, INRA, 37380 Nouzilly, France. ³LPGP, INRA, 35000 Rennes, France. ⁴UMR6625, Agrocampus Ouest, IRMAR, 35000 Rennes, France. ⁵Current address: Programme Cartes d'Identité des Tumeurs (CIT), Ligue Nationale Contre Le Cancer, 75013 Paris, France. ⁶Current address, Institut Pasteur, INSERM U933, 75015 Paris, France.

Received: 28 September 2017 Accepted: 31 January 2018

Published online: 07 March 2018

### References

1. Plavnik I, Wax E, Sklan D, Bartov I, Hurwitz S. The response of broiler chickens and turkey poults to dietary energy supplied either by fat or carbohydrates. Poult Sci. 1997;76:1000-5.

2. null A, Palo PE, Sell JL, et al. Poult Sci. 1996;75:1012-7.

3. Baéza E, Gondret F, Chartrin P, Le Bihan-Duval E, Berri C, Gabriel I, et al. The ability of genetically lean or fat slow-growing chickens to synthesize and store lipids is not altered by the dietary energy source. Anim Int J Anim Biosci. 2015;9:1643-52.

4. Gondret F, Louveau I, Mourot J, Duclos MJ, Lagarrigue S, Gilbert H, et al. Dietary energy sources affect the partition of body lipids and the hierarchy of energy metabolic pathways in growing pigs differing in feed efficiency. J Anim Sci. 2014;92:4865-77.

5. Désert C, Merlot E, Zerjal T, Bed'hom B, Härtle S, Le Cam A, et al. Transcriptomes of whole blood and PBMC in chickens. Comp Biochem Physiol. 2016;20:1-9. Part D Genomics Proteomics.

6. Mach N, Gao Y, Lemonnier G, Lecardonnel J, Oswald IP, Estellé J, et al. The peripheral blood transcriptome reflects variations in immunity traits in swine: towards the identification of biomarkers. BMC Genomics. 2013;14:894.

7. Jung UJ, Seo YR, Ryu R, Choi M-S. Differences in metabolic biomarkers in the blood and gene expression profiles of peripheral blood mononuclear cells among normal weight, mildly obese and moderately obese subjects. Br J Nutr. 2016;116:1022-32.

8. Leclercq B. Genetic selection of meat-type chickens for high or low abdominal fat content. In: Leanness in domestic birds: genetic, metabolic and hormonal aspects. London: Butterworths & Co. Ltd-INRA; 1988. p. 25-40.

9. Chartrin P, Berri C, Le Bihan-Duval E, Quentin M, Baéza E. Influence of production system (label, standard, certified) on lipid and fatty acid composition of fresh and cured-cooked chicken meat. Arch Für Geflügelkd. 2005;69:219-25.

10. Baéza E, Jégou M, Gondret F, Lalande-Martin J, Tea I, Le Bihan-Duval E, et al. Pertinent plasma indicators of the ability of chickens to synthesize and store lipids. J Anim Sci. 2015;93:107-16.

11. Dalrymple RH, Hamm R. A method for the extraction of glycogen and metabolites from a single muscle sample. Int J Food Sci Technol. 1973;8: 439-44.

12. Désert C, Duclos MJ, Blavy P, Lecerf F, Moreews F, Klopp C, et al. Transcriptome profiling of the feeding-to-fasting transition in chicken liver. BMC Genomics. 2008;9:611.

13. Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.

14. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol. 1995;57:289-300.

15. Dvinge H, Bertone P. HTqPCR: high-throughput analysis and visualization of quantitative real-time PCR data in R. Bioinforma Oxf Engl. 2009;25:3325-6.

16. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002; 3:RESEARCH0034.
17. Bazin R, Ferré P. Assays of lipogenic enzymes. Methods Mol Biol Clifton NJ. 2001;155:121–7.

18. Supek F, Bošnjak M, Škunca N, Šmuc T. REVIGO summarizes and visualizes long lists of gene ontology terms. PLoS One. 2011;6:e21800.

19. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44–57.

20. Zhang B, Horvath S. A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol. 2005;4:Article17.

21. Abdi H, Williams LJ, Valentin D. Multiple factor analysis: principal component analysis for multitable and multiblock data sets. Wiley Interdiscip Rev Comput Stat. 2013;5:149–79.

22. Beauclercq S, Hennequet-Antier C, Praud C, Godet E, Collin A, Tesseraud S, et al. Muscle transcriptome analysis reveals molecular pathways and biomarkers involved in extreme ultimate pH and meat defect occurrence in chicken. Sci Rep. 2017;7:6447.

23. Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H, et al. The Gencode v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012;22:1775–89.

24. Fagerberg L, Hallström BM, Oksvold P, Kampf C, Djureinovic D, Odeberg J, et al. Analysis of the human tissue-specific expression by genome-wide integration of Transcriptomics and antibody-based proteomics. Mol Cell Proteomics. 2014;13:397–406.

25. Muret K, Klopp C, Wucher V, Esquerré D, Legeai F, Lecerf F, et al. Long noncoding RNA repertoire in chicken liver and adipose tissue. Genet Sel Evol GSE. 2017;49:6.

26. Shimano H, Shimomura I, Hammer RE, Herz J, Goldstein JL, Brown MS, et al. Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene. J Clin Invest. 1997;100:2115–24.

27. Peet DJ, Janowski BA, Mangelsdorf DJ. The LXRs: a new class of oxysterol receptors. Curr Opin Genet Dev. 1998;8:571–5.

28. Ducheix S, Lobaccaro JMA, Martin PG, Guillou H. Liver X receptor: an oxysterol sensor and a major player in the control of lipogenesis. Chem Phys Lipids. 2011;164:500–14.

29. Iizuka K, Bruick RK, Liang G, Horton JD, Uyeda K. Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis. Proc Natl Acad Sci U S A. 2004;101:7281–6.

30. Dentin R, Girard J, Postic C. Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liver. Biochimie. 2005;87:81–6.

31. Somel M, Creely H, Franz H, Mueller U, Lachmann M, Khaitovich P, et al. Human and chimpanzee gene expression differences replicated in mice fed different diets. PLoS One. 2008;3:e1504.

32. Do G-M, Oh HY, Kwon E, Cho Y, Shin S, Park H-J, et al. Long-term adaptation of global transcription and metabolism in the liver of high-fat diet-fed C57BL/6J mice. Mol Nutr Food Res. 2011;55(Suppl 2):S173–85.

33. Amacher DE, Schomaker SJ, Boldt SE, Mirsky M. The relationship among microsomal enzyme induction, liver weight, and histological change in cynomolgus monkey toxicology studies. Food Chem Toxicol Int J Publ Br Ind Biol Res Assoc. 2006;44:528–37.

34. Porter RE. Bacterial enteritides of poultry. Poult Sci. 1998;77:1159–65.

35. Hilton JW, Atkinson JL. Response of rainbow trout (Salmo Gairdneri) to increased levels of available carbohydrate in practical trout diets. Br J Nutr. 1982;47:597–607.

36. Leveille GA, Chakrabarty K. Diurnal variations in tissue glycogen and liver weight of meal-fed rats. J Nutr. 1967;93:546–54.

37. Smith SJ, Cases S, Jensen DR, Chen HC, Sande E, Tow B, et al. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat. Nat Genet. 2000;25:87–90.

38. Irwin DM, Tan H. Molecular evolution of the vertebrate hexokinase gene family: identification of a conserved fifth vertebrate hexokinase gene. Comp Biochem Physiol. 2008;3:96–107. Part D Genomics Proteomics.

39. Guo C, Ludvik AE, Arlotto ME, Hayes MG, Armstrong LL, Scholtens DM, et al. Coordinated regulatory variation associated with gestational hyperglycaemia regulates expression of the novel hexokinase HKDC1. Nat Commun. 2015;6:6069.

40. Sugden MC, Bulmer K, Holness MJ. Fuel-sensing mechanisms integrating lipid and carbohydrate utilization. Biochem Soc Trans. 2001;29:272–8.

41. Jump DB, Clarke SD. Regulation of gene expression by dietary fat. Annu Rev Nutr. 1999;19:63–90.

42. Nakamura MT, Yudell BE, Loor JJ. Regulation of energy metabolism by long-chain fatty acids. Prog Lipid Res. 2014;53:124–44.

43. Jump DB. Fatty acid regulation of hepatic lipid metabolism. Curr Opin Clin Nutr Metab Care. 2011;14:115–20.

44. Assaf S, Hazard D, Pitel F, Morisson M, Alizadeh M, Gondret F, et al. Cloning of cDNA encoding the nuclear form of chicken sterol response element binding protein-2 (SREBP-2), chromosomal localization, and tissue expression of chicken SREBP-1 and -2 genes. Poult Sci. 2003;82:54–61.

45. O'Hea EK, Leveille GA. Lipid biosynthesis and transport in the domestic chick (Gallus Domesticus). Comp Biochem Physiol. 1969;30:149–59.

46. Moon YA, Lee JJ, Park SW, Ahn YH, Kim KS. The roles of sterol regulatory element-binding proteins in the transactivation of the rat ATP citrate-lyase promoter. J Biol Chem. 2000;275:30280–6.

47. Sato R, Okamoto A, Inoue J, Miyamoto W, Sakai Y, Emoto N, et al. Transcriptional regulation of the ATP citrate-lyase gene by sterol regulatory element-binding proteins. J Biol Chem. 2000;275:12497–502.

48. Magaña MM, Lin SS, Dooley KA, Osborne TF. Sterol regulation of acetyl coenzyme a carboxylase promoter requires two interdependent binding sites for sterol regulatory element binding proteins. J Lipid Res. 1997;38:1630–8.

49. Yin L, Zhang Y, Hillgartner FB. Sterol regulatory element-binding protein-1 interacts with the nuclear thyroid hormone receptor to enhance acetyl-CoA carboxylase-alpha transcription in hepatocytes. J Biol Chem. 2002;277: 19554–65.

50. Zhang Y, Yin L, Hillgartner FB. SREBP-1 integrates the actions of thyroid hormone, insulin, cAMP, and medium-chain fatty acids on ACCalpha transcription in hepatocytes. J Lipid Res. 2003;44:356–68.

51. Bennett MK, Lopez JM, Sanchez HB, Osborne TF. Sterol regulation of fatty acid synthase promoter. Coordinate feedback regulation of two major lipid pathways. J Biol Chem. 1995;270:25578–83.

52. Magaña MM, Koo SH, Towle HC, Osborne TF. Different sterol regulatory element-binding protein-1 isoforms utilize distinct co-regulatory factors to activate the promoter for fatty acid synthase. J Biol Chem. 2000;275:4726–33.

53. Matsuzaka T, Shimano H, Yahagi N, Yoshikawa T, Amemiya-Kudo M, Hasty AH, et al. Cloning and characterization of a mammalian fatty acyl-CoA elongase as a lipogenic enzyme regulated by SREBPs. J Lipid Res. 2002;43: 911–20.

54. Tabor DE, Kim JB, Spiegelman BM, Edwards PA. Identification of conserved cis-elements and transcription factors required for sterol-regulated transcription of stearoyl-CoA desaturase 1 and 2. J Biol Chem. 1999;274: 20603–10.

55. Hannah VC, Ou J, Luong A, Goldstein JL, Brown MS. Unsaturated fatty acids down-regulate srebp isoforms 1a and 1c by two mechanisms in HEK-293 cells. J Biol Chem. 2001;276:4365–72.

56. Ou J, Tu H, Shan B, Luk A, DeBose-Boyd RA, Bashmakov Y, et al. Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc Natl Acad Sci U S A. 2001;98:6027–32.

57. Ducheix S, Montagner A, Polizzi A, Lasserre F, Marmugi A, Bertrand-Michel J, et al. Essential fatty acids deficiency promotes lipogenic gene expression and hepatic steatosis through the liver X receptor. J Hepatol. 2013;58:984–92.

58. Dentin R, Pégorier J-P, Benhamed F, Foufelle F, Ferré P, Fauveau V, et al. Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression. J Biol Chem. 2004; 279:20314–26.

59. Ishii S, Iizuka K, Miller BC, Uyeda K. Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription. Proc Natl Acad Sci U S A. 2004;101:15597–602.

60. Dubuquoy C, Robichon C, Lasnier F, Langlois C, Dugail I, Foufelle F, et al. Distinct regulation of adiponutrin/PNPLA3 gene expression by the transcription factors ChREBP and SREBP1c in mouse and human hepatocytes. J Hepatol. 2011;55:145–53.

61. Yamashita H, Takenoshita M, Sakurai M, Bruick RK, Henzel WJ, Shillinglaw W, et al. A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc Natl Acad Sci U S A. 2001;98:9116–21.

62. Stoeckman AK, Ma L, Towle HC. Mlx is the functional heteromeric partner of the carbohydrate response element-binding protein in glucose regulation of lipogenic enzyme genes. J Biol Chem. 2004;279:15662–9.

63. Higashiyama H, Billin AN, Okamoto Y, Kinoshita M, Asano S. Expression profiling of peroxisome proliferator-activated receptor-delta (PPAR-delta) in mouse tissues using tissue microarray. Histochem Cell Biol. 2007;127:485–94.
64. Tan NS, Vázquez-Carrera M, Montagner A, Sng MK, Guillou H, Wahli W. Transcriptional control of physiological and pathological processes by the nuclear receptor PPARβ/δ. Prog Lipid Res. 2016;64:98–122.

65. Lee C-H, Olson P, Hevener A, Mehl I, Chong L-W, Olefsky JM, et al. PPARdelta regulates glucose metabolism and insulin sensitivity. Proc Natl Acad Sci U S A. 2006;103:3444–9.

66. Liu S, Hatano B, Zhao M, Yen C-C, Kang K, Reilly SM, et al. Role of peroxisome proliferator-activated receptor (delta)/[beta] in hepatic metabolic regulation. J Biol Chem. 2011;286:1237–47.

67. Liu S, Brown JD, Stanya KJ, Homan E, Leidl M, Inouye K, et al. A diurnal serum lipid integrates hepatic lipogenesis and peripheral fatty acid use. Nature. 2013;502:550–4.

68. Hilberg F, Aguzzi A, Howells N, Wagner EF. C-jun is essential for normal mouse development and hepatogenesis. Nature. 1993;365:179–81.

69. Eferl R, Ricci R, Kenner L, Zenz R, David J-P, Rath M, et al. Liver tumor development. C-Jun antagonizes the proapoptotic activity of p53. Cell. 2003;112:181–92.

70. Guo J, Fang W, Sun L, Lu Y, Dou L, Huang X, et al. Reduced miR-200b and miR-200c expression contributes to abnormal hepatic lipid accumulation by stimulating JUN expression and activating the transcription of srebp1. Oncotarget. 2016;7:36207–19.

71. Skiba-Cassy S, Collin A, Chartrin P, Médalet F, Simon J, Duclos MJ, et al. Chicken liver and muscle carnitine palmitoyltransferase 1: nutritional regulation of messengers. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 2007;147:278–87.

72. Régnier M, Polizzi A, Lippi Y, Fouché E, Michel G, Lukowicz C, et al. Insights into the role of hepatocyte PPARα activity in response to fasting. Mol Cell Endocrinol. 2017.

73. Petrov PD, Bonet ML, Reynés B, Oliver P, Palou A, Ribot J. Whole blood RNA as a source of transcript-based nutrition- and metabolic health-related biomarkers. PLoS One. 2016;11:e0155361.

74. Jégou M, Gondret F, Vincent A, Tréfeu C, Gilbert H, Louveau I. Whole blood Transcriptomics is relevant to identify molecular changes in response to genetic selection for feed efficiency and nutritional status in the pig. PLoS One. 2016;11:e0146550.

75. Travers MT, Cambot M, Kennedy HT, Lenoir GM, Barber MC, Joulin V. Asymmetric expression of transcripts derived from the shared promoter between the divergently oriented ACACA and TADA2L genes. Genomics. 2005;85:71–84.

76. Shi X, Metges CC, Seyfert H-M. Characterization of a far upstream located promoter expressing the acetyl-CoA carboxylase-alpha in the brain of cattle. Gene. 2013;515:266–71.

77. El Khadir-Mounier C, Le Fur N, Powell RS, Diot C, Langlois P, Mallard J, et al. Cloning and characterization of the 5' end and promoter region of the chicken acetyl-CoA carboxylase gene. Biochem J. 1996;314(Pt 2):613–9.

78. Barber MC, Price NT, Travers MT. Structure and regulation of acetyl-CoA carboxylase genes of metazoa. Biochim Biophys Acta. 2005;1733:1–28.

79. Yang C-Y, Chiu L-L, Tan T-H. TRAF2-mediated Lys63-linked ubiquitination of DUSP14/MKP6 is essential for its phosphatase activity. Cell Signal. 2016;28:145–51.

80. Huang C-Y, Tan T-H. DUSPs, to MAP kinases and beyond. Cell Biosci. 2012;2:24.

81. Nagy Z, Riss A, Fujiyama S, Krebs A, Orpinell M, Jansen P, et al. The metazoan ATAC and SAGA coactivator HAT complexes regulate different sets of inducible target genes. Cell Mol Life Sci CMLS. 2010;67:611–28.

82. Spedale G, Timmers HTM, Pijnappel WWMP. ATAC-king the complexity of SAGA during evolution. Genes Dev. 2012;26:527–41.

83. Guelman S, Kozuka K, Mao Y, Pham V, Solloway MJ, Wang J, et al. The double-histone-acetyltransferase complex ATAC is essential for mammalian development. Mol Cell Biol. 2009;29:1176–88.

84. Nguyen LN, Ma D, Shui G, Wong P, Cazenave-Gassiot A, Zhang X, et al. Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid. Nature. 2014;509:503–6.

85. Ben-Zvi A, Lacoste B, Kur E, Andreone BJ, Mayshar Y, Yan H, et al. Mfsd2a is critical for the formation and function of the blood-brain barrier. Nature. 2014;509:507–11.

86. Angers M, Uldry M, Kong D, Gimble JM, Jetten AM. Mfsd2a encodes a novel major facilitator superfamily domain-containing protein highly induced in brown adipose tissue during fasting and adaptive thermogenesis. Biochem J. 2008;416:347–55.

87. Berger JH, Charron MJ, Silver DL. Major facilitator superfamily domain-containing protein 2a (MFSD2A) has roles in body growth, motor function, and lipid metabolism. PLoS One. 2012;7:e50629.

88. Chamoun Z, Vacca F, Parton RG, Gruenberg J. PNPLA3/adiponutrin functions in lipid droplet formation. Biol Cell. 2013;105:219–33.

89. Maxfield FR, Iaea DB, Pipalia NH. Role of STARD4 and NPC1 in intracellular sterol transport. Biochem Cell Biol Biochim Biol Cell. 2016;94:499–506.

90. Freake HC, Oppenheimer JH. Stimulation of S14 mRNA and lipogenesis in brown fat by hypothyroidism, cold exposure, and cafeteria feeding: evidence supporting a general role for S14 in lipogenesis and lipogenesis in the maintenance of thermogenesis. Proc Natl Acad Sci U S A. 1987;84:3070–4.

91. Jump DB, Narayan P, Towle H, Oppenheimer JH. Rapid effects of triiodothyronine on hepatic gene expression. Hybridization analysis of tissue-specific triiodothyronine regulation of mRNAs14. J Biol Chem. 1984; 259:2789–97.

92. Jump DB, Oppenheimer JH. High basal expression and 3,5,3'-triodothyronine regulation of messenger ribonucleic acid S14 in lipogenic tissues. Endocrinology. 1985;117:2259–66.

93. Kinlaw WB, Schwartz HL, Towle HC, Oppenheimer JH. Opposing effects of glucagon and triiodothyronine on the hepatic levels of messenger ribonucleic acid S14 and the dependence of such effects on circadian factors. J Clin Invest. 1986;78:1091–6.

94. Narayan P, Liaw CW, Towle HC. Rapid induction of a specific nuclear mRNA precursor by thyroid hormone. Proc Natl Acad Sci U S A. 1984;81:4687–91.

95. Towle HC, Mariash CN. Regulation of hepatic gene expression by lipogenic diet and thyroid hormone. Fed Proc. 1986;45:2406–11.

96. Zilz ND, Murray MB, Towle HC. Identification of multiple thyroid hormone response elements located far upstream from the rat S14 promoter. J Biol Chem. 1990;265:8136–43.

97. Breuker C, Moreau A, Lakhal L, Tamasi V, Parmentier Y, Meyer U, et al. Hepatic expression of thyroid hormone-responsive spot 14 protein is regulated by constitutive androstane receptor (NR113). Endocrinology. 2010; 151:1653–61.

98. Wu J, Wang C, Li S, Li S, Wang W, Li J, et al. Thyroid hormone-responsive SPOT 14 homolog promotes hepatic lipogenesis, and its expression is regulated by liver X receptor α through a sterol regulatory element-binding protein 1c-dependent mechanism in mice. Hepatol. Baltim. Md. 2013;58: 617–28.

99. Zanetti G, Pahuja KB, Studer S, Shim S, Schekman R. COPII and the regulation of protein sorting in mammals. Nat Cell Biol. 2011;14:20–8.

100. Han J, Li E, Chen L, Zhang Y, Wei F, Liu J, et al. The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1. Nature. 2015;524: 243–6.

101. Nagy Z, Tora L. Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation. Oncogene. 2007;26:5341–57.

102. Qiao A, Liang J, Ke Y, Li C, Cui Y, Shen L, et al. Mouse patatin-like phospholipase domain-containing 3 influences systemic lipid and glucose homeostasis. Hepatol Baltim Md. 2011;54:509–21.

103. Joseph SB, Laffitte BA, Patel PH, Watson MA, Matsukuma KE, Walczak R, et al. Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. J Biol Chem. 2002;277:11019–25.

104. Demeure O, Duby C, Desert C, Assaf S, Hazard D, Guillou H, et al. Liver X receptor alpha regulates fatty acid synthase expression in chicken. Poult Sci. 2009;88:2628–35.

105. Chu K, Miyazaki M, Man WC, NTambi JM. Stearoyl-coenzyme a desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation. Mol Cell Biol. 2006;26:6786–98.

106. Cha J-Y, Repa JJ. The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR. J Biol Chem. 2007;282:743–51.

107. Foster DW. Malonyl-CoA: the regulator of fatty acid synthesis and oxidation. J Clin Invest. 2012;122:1958–9.